BTG Plc (BTG) - Product Pipeline Analysis, 2018 Update

Summary

BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BTG Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 4
List of Figures 5
BTG Plc Company Overview 6
BTG Plc Company Snapshot 6
BTG Plc Pipeline Products and Ongoing Clinical Trials Overview 6
BTG Plc Pipeline Analysis Overview 9
Business Description 9
BTG Plc - Key Facts 9
BTG Plc - Major Products and Services 10
BTG Plc Pipeline Products by Development Stage 11
BTG Plc Ongoing Clinical Trials by Trial Status 13
BTG Plc Pipeline Products Overview 16
CellBead - Neuro 16
CellBead - Neuro Product Overview 16
Cryotherapy Ablation System - Bone and Soft Tissue 17
Cryotherapy Ablation System - Bone and Soft Tissue Product Overview 17
Cryotherapy Ablation System - Liver Metastasis 18
Cryotherapy Ablation System - Liver Metastasis Product Overview 18
Cryotherapy Ablation System - Lung Metastasis 19
Cryotherapy Ablation System - Lung Metastasis Product Overview 19
DC Bead 20
DC Bead Product Overview 20
DC Bead Clinical Trial 21
DC Bead M1 22
DC Bead M1 Product Overview 22
DC Bead M1 Clinical Trial 23
EKOS Control Unit - New 24
EKOS Control Unit - New Product Overview 24
EkoSonic Endovascular System 25
EkoSonic Endovascular System Product Overview 25
EkoSonic Endovascular System Clinical Trial 26
Ibuprofen Bead 28
Ibuprofen Bead Product Overview 28
LC Bead LUMI 29
LC Bead LUMI Product Overview 29
LC Bead LUMI Clinical Trial 30
PARAGON Bead 32
PARAGON Bead Product Overview 32
PneumRx RePneu Coil System 33
PneumRx RePneu Coil System Product Overview 33
PneumRx RePneu Coil System Clinical Trial 34
TheraSphere - mCRC 36
TheraSphere - mCRC Product Overview 36
TheraSphere - mCRC Clinical Trial 37
Varithena - Aesthetic Leg Veins 38
Varithena - Aesthetic Leg Veins Product Overview 38
Vetex Thrombectomy Device 39
Vetex Thrombectomy Device Product Overview 39
Vetex Thrombectomy Device Clinical Trial 40
BTG Plc - Key Competitors 41
BTG Plc - Key Employees 42
BTG Plc - Key Employee Biographies 43
BTG Plc - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 47
BTG Plc, Recent Developments 47
Jul 19, 2018: Jeffrey Newman Law Announces $11.5 Million Settlement In Whistleblower Fraud Case Against Medical Device Distributor AngioDynamics For Selling Gelsphere Device For Unapproved Chemotherapy Eluting Purposes 47
Jun 15, 2018: Result Of FDA Advisory Committee Vote On Elevair For The Treatment Of Severe Emphysema 47
Jun 11, 2018: ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx Endobronchial Coil System 48
May 15, 2018: BTG: Final Results For year ended 31 March 2018 49
Apr 27, 2018: OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions 54
Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program 55
Mar 27, 2018: Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy With the CyberKnife System 56
Feb 06, 2018: OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS Therapy For Pulmonary Embolism 57
Dec 14, 2017: Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS Therapy Protocols for Pulmonary Embolism 58
Dec 12, 2017: Northwestern University adopts Y90 TARE with TheraSphere as first-line treatment for HCC 58
Appendix 60
Methodology 60
About GlobalData 63
Contact Us 63
Disclaimer 63

List Of Tables


BTG Plc Pipeline Products and Ongoing Clinical Trials Overview 6
BTG Plc Pipeline Products by Equipment Type 7
BTG Plc Pipeline Products by Indication 8
BTG Plc Ongoing Clinical Trials by Trial Status 8
BTG Plc, Key Facts 9
BTG Plc, Major Products and Services 10
BTG Plc Number of Pipeline Products by Development Stage 11
BTG Plc Pipeline Products Summary by Development Stage 12
BTG Plc Ongoing Clinical Trials by Trial Status 13
BTG Plc Ongoing Clinical Trials Summary 14
CellBead - Neuro - Product Status 16
CellBead - Neuro - Product Description 16
Cryotherapy Ablation System - Bone and Soft Tissue - Product Status 17
Cryotherapy Ablation System - Bone and Soft Tissue - Product Description 17
Cryotherapy Ablation System - Liver Metastasis - Product Status 18
Cryotherapy Ablation System - Liver Metastasis - Product Description 18
Cryotherapy Ablation System - Lung Metastasis - Product Status 19
Cryotherapy Ablation System - Lung Metastasis - Product Description 19
DC Bead - Product Status 20
DC Bead - Product Description 20
DC Bead - Phase 4, to Assess Time to Progression (TTP) and Safety Profile of Doxorubicin-Eluting-Bead Embolization(DEBDOX) in Patients with Advanced HCC 21
DC Bead - Safety and Efficacy of Drug-eluting Beads Trans-arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan: SERENADE-T 21
DC Bead M1 - Product Status 22
DC Bead M1 - Product Description 22
DC Bead M1 - Efficacy and Tolerability of Doxorubicin-eluting DC Bead M1 for Hepatocellular Carcinoma (HCC) 23
EKOS Control Unit - New - Product Status 24
EKOS Control Unit - New - Product Description 24
EkoSonic Endovascular System - Product Status 25
EkoSonic Endovascular System - Product Description 25
EkoSonic Endovascular System - Retrospective and Prospective International Ekosonic Registry of the Treatment and Clinical Outcomes of Patients with Pulmonary Embolism 26
EkoSonic Endovascular System - Study of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in the Treatment of Acute Submassive Pulmonary Embolism 26
EkoSonic Endovascular System - Submassive Pulmonary Embolism Experience with EKOS 27
Ibuprofen Bead - Product Status 28
Ibuprofen Bead - Product Description 28
LC Bead LUMI - Product Status 29
LC Bead LUMI - Product Description 29
LC Bead LUMI - A Phase II Study Using LC Bead LUMI Radio-opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment with Transarterial Embolization (TAE) Alone or Combined with Thermal Ablation 30
LC Bead LUMI - A Window of Opportunity Study of Vandetanib-eluting Radiopaque Embolic Beads (BTG-002814) in Patients with Resectable Liver Malignancies: VEROnA 30
LC Bead LUMI - LC Bead LUMI for Prostatic Artery Embolization: A Pilot Study 31
PARAGON Bead - Product Status 32
PARAGON Bead - Product Description 32
PneumRx RePneu Coil System - Product Status 33
PneumRx RePneu Coil System - Product Description 33
PneumRx RePneu Coil System - A Randomized Controlled Study of PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema 34
PneumRx RePneu Coil System - Changes in Lung Physiology and Cardiac Performance in Patients with Emphysema Post Bilateral RePneu Coil Treatment 34
PneumRx RePneu Coil System - Crossover From IDE Trial CLN0009, Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study, IDE G110066 34
PneumRx RePneu Coil System - Identifying Responders and Exploring Mechanisms of Action of the Endobronchial Coil Treatment for Emphysema 35
PneumRx RePneu Coil System - Lung Volume Reduction Coil Treatment in Patients with Emphysema: RENEW Study 35
PneumRx RePneu Coil System - Post Market Observational, Prospective, Multi-center Registry Using the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) System 35
TheraSphere - mCRC - Product Status 36
TheraSphere - mCRC - Product Description 36
TheraSphere - mCRC - A Phase III Clinical Trial Evaluating Therasphere in Patients with Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy 37
TheraSphere - mCRC - RadioEmbolization for the Advancement of Y90 Glass Microspheres Registry 37
Varithena - Aesthetic Leg Veins - Product Status 38
Varithena - Aesthetic Leg Veins - Product Description 38
Vetex Thrombectomy Device - Product Status 39
Vetex Thrombectomy Device - Product Description 39
Vetex Thrombectomy Device - The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation 40
BTG Plc, Key Employees 42
BTG Plc, Key Employee Biographies 43
BTG Plc, Subsidiaries 44
Glossary 62

List Of Figures


BTG Plc Pipeline Products by Equipment Type 7
BTG Plc Pipeline Products by Development Stage 11
BTG Plc Ongoing Clinical Trials by Trial Status 13

BTG Plc - Strategic SWOT Analysis Review

BTG Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

BTG Plc (BTG) - Product Pipeline Analysis, 2018 Update

BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines

USD 750 View Report

BTG Plc - Strategic SWOT Analysis Review

BTG Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

BTG PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

BTG PLC Company Profile is a detailed strategic and analytical report on BTG PLC. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available